EBP Compendium: Summary of Clinical Practice Guideline
Royal College of Speech & Language Therapists; Department of Health (UK); National Institute for Clinical Excellence (NICE)
RCSLT Clinical Guidelines: 5.11 Dysarthria
Taylor-Goh, S., ed.
RCSLT Clinical Guidelines. Bicester, Speechmark Publishing Ltd.
AGREE Rating: Highly Recommended
This guideline provides recommendations for the assessment and management of dysarthria in children and adults. This guideline is intended for primary use by speech-language pathologists (SLPs). Each recommendation is graded A (requires at least one randomized controlled trial), B (requires at least one well-conducted clinical study), or C (requires evidence from expert committee reports).
- General Findings - The SLP should provide an “explanation of the normal anatomy and physiology of the orofacial tract and speech production” and explain possible causal and maintaining factors and factors to the client (Level C Evidence) (p. 95).
- Oral-Motor Treatments - “Where the aim is to reduce the degree of impairment or increase the physiological support for speech, a physiological approach may be appropriate. This may occur separately or in combination with either or both a compensatory and/or augmentative approach” (Level A Evidence) (p. 96).
- Compensatory Treatments - “Where the aim is to minimize the effect of the overall disability and promote intelligibility, various compensatory approaches should be used. These may occur separately or in combination with a compensatory and/or augmentative approach” (Level B Evidence) (p. 96).
- AAC -"When speech alone is insufficient to meet the individual’s communication needs, a variety of augmentative strategies should be used” (Level B Evidence) (p. 96).
Access the Guideline
Added to Compendium: November 2010